scispace - formally typeset
B

Betty L. Slagle

Researcher at Baylor College of Medicine

Publications -  61
Citations -  10292

Betty L. Slagle is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: Hepatitis B virus & HBx. The author has an hindex of 33, co-authored 61 publications receiving 9335 citations. Previous affiliations of Betty L. Slagle include Swiss Institute of Bioinformatics & Texas Medical Center.

Papers
More filters
Journal ArticleDOI

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

TL;DR: Observations indicate that a normal p53 gene is dispensable for embryonic development, that its absence predisposes the animal to neoplastic disease, and that an oncogenic mutant form of p53 is not obligatory for the genesis of many types of tumours.
Journal ArticleDOI

Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma

Adrian Ally, +235 more
- 15 Jun 2017 - 
TL;DR: Integrative molecular HCC subtyping incorporating unsupervised clustering of five data platforms identified three subtypes, one of which was associated with poorer prognosis in three HCC cohorts and development of a p53 target gene expression signature correlating with poor survival was enabled.
Journal ArticleDOI

Hepatitis B virus X protein interferes with cellular DNA repair.

TL;DR: Results are consistent with a model in which HBx acts as a cofactor in hepatocarcinogenesis by preventing the cell from efficiently repairing damaged DNA, thus leading to an accumulation of DNA mutations and, eventually, cancer.
Journal ArticleDOI

Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype.

TL;DR: A role for these miRNAs in the maintenance of the malignant transformation of hepatocytes is supported, and separate treatments with antisense oligonucleotides specific for either the miR-17-92 polycistron (all six members) or mi-21 caused a 50% reduction in both hepatocyte proliferation and anchorage-independent growth.